Role of Glucose in the Expression of Cryptococcus neoformans Antiphagocytic Protein 1, App1

Eukaryotic Cell

Volumn 10, Issue 3, 2011, Pages 293-301

  Williams, Virginia ^a   del Poeta, Maurizio ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APP1 PROTEIN, CRYPTOCOCCUS NEOFORMANS; CARRIER PROTEIN; GLUCOSE;

ANIMAL; ARTICLE; CBA MOUSE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MICROBIOLOGY; MOUSE; PATHOGENICITY; UPREGULATION; VIRULENCE;

ANIMALS; CARRIER PROTEINS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; GENE EXPRESSION REGULATION, FUNGAL; GLUCOSE; HUMANS; MALE; MICE; MICE, INBRED CBA; UP-REGULATION; VIRULENCE;

FILOBASIDIELLA NEOFORMANS; MAMMALIA;

EID: 79952309789     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00252-10     Document Type: Article

References (50)

1. Alspaugh, J. A., J. R. Perfect, and J. Heitman. 1997. Cryptococcus neoformans mating and virulence are regulated by the G-protein a subunit GPA1 and cAMP. Genes Dev. 11: 3206-3217.
2. Alspaugh, J. A., et al. 2002. Adenylyl cyclase functions downstream of the Ga protein Gpa1 and controls mating and pathogenicity of Cryptococcus neoformans. Eukaryot. Cell 1: 75-84.
3. Bahn, Y.-S., et al. 2007. Sensing the environment: lessons from fungi. Nat. Rev. Microbiol. 5: 57-69.
4. Bandyopadhyay, S., T. K. Sengupta, and E. K. Spicer. 2008. PMA induces stabilization of oncostatin M in mRNA in human lymphoma U937 cells. Biochem. J. 410: 177-186.
5. Bhat, P. J., and R. S. Iyer. 2009. Epigenetics of the yeast galactose genetic switch. J. Biosci. 34: 513-522.
6. Bradford, M. M. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
7. Brown, V., J. Sabina, and M. Johnston. 2009. Specialized sugar sensing in diverse fungi. Curr. Biol. 10: 436-441.
8. Carlson, M. 1987. Regulation of sugar utilization in Saccharomyces species. J. Bacteriol. 169: 4873-4877.
9. Carlson, M. 1999. Glucose repression in yeast. Curr. Opin. Microbiol. 2: 202-207.
10. Casadevall, A., and J. R. Perfect. 1998. Cryptococcus neoformans, p. 381-405. ASM Press, Washington, DC.
11. Cereghino, G. P., D. P. Atencio, M. Saghbini, J. Beiner, and I. E. Scheffer. 1995. Glucose-dependent turnover of the mRNAs encoding succinate dehydrogenase peptides in Saccharomyces cerevisiae: sequence elements in the 5′ untranslated region of the Ip mRNA play a dominant role. Mol. Biol. Cell 6: 1125-1143.
12. Elferink, C. J., and J. Reiners, Jr. 1996. Quantitative RT-PCR on CYP1A1 heterogeneous nuclear RNA: a surrogate for the in vitro transcription run-on assay. Biotechniques 20: 470-477.
13. Feldmesser, M., Y. Kress, P. Novikoff, and A. Casadevall. 2000. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect. Immun. 68: 4225-4237.
14. Feldmesser, M., S. Tucker, and A. Casadevall. 2001. Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol. 9: 273-278.
15. Ferenczi, S., E. Zelei, B. Pinter, Z. Szoke, and K. J. Kovacs. 2010. Differential regulation of hypothalmic neuropeptide Y hnRNA and mRNA during psychological stress and insulin-induced hypoglycemia. Mol. Cell. Endocrinol. 321: 138-145.
16. Gelade, R., S. Van de Velde, P. Van Dijck, and J. M. Thevelein. 2003. Multi-level response of the yeast genome to glucose. Genome Biol. 4: 233.
17. Harlow, E., and D. Lane. 1988. Antibodies. A laboratory manual, p. 274. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
18. Heung, L. J., A. E. Kaiser, C. Luberto, and M. Del Poeta. 2005. The role and mechanism of diacylglycerol protein kinase C1 signaling in melanogenesis by Cryptococcus neoformans. J. Biol. Chem. 280: 28547-28555.
19. Hu, G., P.-Y. Cheng, A. Sham, J. R. Perfect, and J. W. Kronstad. 2008. Metabolic adaption in Cryptococcus neoformans during early pulmonary infection. Mol. Microbiol. 69: 1456-1475.
20. Ishimaru, D., et al. 2009. Regulation of Bcl-1 expression by hur in HL60 leukemia cells and A431 carcinoma cells. Mol. Cancer Res. 7: 1354-1366.
21. Johnston, M. 1999. Feasting, fasting, and fermenting glucose sensing in yeast and other cells. Trends Genet. 15: 29-33.
22. Kalsi, K. K., et al. 2009. Glucose homeostasis across human airway epithelial cell monolayers: role of diffusion, transport and metabolism. Eur. J. Physiol. 457: 1061-1070.
23. Laurent, B. C., M. A. Treitel, and M. Carlson. 1990. The SNF5 protein of Saccharomyces cerevisiae is a glutamine-and-proline-rich transcriptional activator that affects expression of a broad spectrum of genes. Mol. Cell. Biol. 10: 5616-5625.
24. Leborgne, N., et al. 1995. Carbohydrate content of Eucalyptus gunnii leaves along an annual cycle in the field and during induced frost-hardening in controlled conditions. Trees 10: 86-93.
25. Levitz, S. M., S.-H. Nong, K. F. Seetoo, T. S. Harrison, R. A. Speizer, and E. R. Simons. 1999. Cryptococcus neoformans resides in the acidic phagolysosome of human macrophages. Infect. Immun. 67: 885-890.
26. Luberto, C., et al. 2003. Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans. J. Clin. Invest. 112: 1080-1094.
27. Luberto, C., et al. 2001. Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of Cryptococcus neoformans. Genes Dev. 15: 201-212.
28. Mare, L., R. Iatta, M. T. Montagna, C. Luberto, and M. Del Poeta. 2005. APP1 transcription is regulated by inositol-phosphorylceramide synthase 1-diacylglycerol pathway in Cryptococcus neoformans. J. Biol. Chem. 280: 36055-36064.
29. Meszaros, K., C. H. Lang, G. J. Bagby, and J. J. Spitzer. 1988. In vivo glucose utilization by individual tissues during nonlethal hypermetabolic sepsis. FASEB J. 2: 3083-3086.
30. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
31. Newsholme, P., and E. A. Newsholme. 1989. Rates of utilization of glucose, glutamine and oleate and formation of end-products by mouse peritoneal macrophages in culture. Biochem. J. 261: 211-218.
32. Nielsen, K., A. L. De Obaldia, and J. Heitman. 2007. Cryptococcus neoformans mates on pigeon guano: implications for the realized ecological niche and globalization. Eukaryot. Cell 6: 949-959.
33. Osterholzer, J. J., et al. 2009. Accumulation of CD11b+ lung dendritic cells in response to fungal infection results from the CCR2-mediated recruitment and differentiation of Ly-6C high monocytes. J. Immunol. 183: 8044-8053.
34. Osterholzer, J. J., et al. 2009. Role of dendritic cells and alveolar macrophages in regulating early host defense against pulmonary infection with Cryptococcus neoformans. Infect. Immun. 77: 3749-3758.
35. Otake, Y., et al. 2007. Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. Blood 109: 3069-3075.
36. Ponzio, T. A., C. Yue, and H. Gainer. 2007. An intron-based real-time PCR method for measuring vasopressin gene transcription. J. Neurosci. Methods 164: 149-154.
37. Pukkila-Worley, R., et al. 2005. Transcriptional network of multiple capsule and melanin genes governed by the Cryptococcus neoformans cyclic AMP cascade. Eukaryot. Cell 4: 190-201.
38. Qureshi, A., et al. 2010. Role of sphingomyelin synthase in controlling the antimicrobial activity of neutrophils against Cryptococcus neoformans. PLoS One 5:e15587.
39. Rhome, R., et al. 2011. Surface localization of glucosylceramide during Cryptococcus neoformans infection allows targeting as a potential antifungal. PLoS One 6:e15572.
40. Rittershaus, P. C., et al. 2006. Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans. J. Clin. Invest. 116: 1651-1659.
41. Sabina, J., and V. Brown. 2009. Glucose sensing network in Candida albicans: a sweet spot for fungal morphogenesis. Eukaryot. Cell 8: 1314-1320.
42. Saumon, G., G. Martet, and P. Loiseau. 1996. Glucose transport and equilibrium across alveolar-airway barrier of rat. Am. J. Physiol. 270:L183-L190.
43. Stano, P., et al. 2009. App1: an antiphagocytic protein that binds to complement receptors 3 and 2. J. Immunol. 182: 84-91.
44. Tommasino, N., et al. 2008. Atf2 transcription factor binds to the App1 promoter in Cryptococcus neoformans: stimulatory effect of diacylglycerol. Eukaryot. Cell 7: 294-301.
45. Walton, F. J., A. Idnurm, and J. Heitman. 2005. Novel gene functions required for melanization of the human pathogen Cryptococcus neoformans. Mol. Microbiol. 57: 1381-1396.
46. Wang, B., et al. 1995. Over-expression of CD3 epsilon transgenes blocks T lymphocyte development. Int. Immunol. 7: 435-448.
47. Wang, B., S. J. Simpson, G. A. Hollander, and C. Terhorst. 1997. Development and function of T lymphocytes and natural killer cells after bone marrow transplantation of severely immunodeficient mice. Immunol. Rev. 157: 53-60.
48. Wang, F., et al. 2010. Short-time effect of heavy metals upon microbial community activity. J. Hazard. Mater. 173: 510-516.
49. Williamson, P. 1994. Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase. J. Bacteriol. 176: 656-664.
50. Xue, C., Y.-S. Bahn, G. M. Cox, and J. Heitman. 2006. G protein-coupled receptor Gpr4 senses amino acids and activates the cAMP-PKA pathway in Cryptococcus neoformans. Mol. Biol. Cell 17: 667-679.